Who is eligible?

The CancerAid Plus Program is an evidence-based program developed by CancerAid, an independent company.  

To meet Medicines Australia requirements, the CancerAid Plus Program is available only for patients prescribed certain medications. For now, this includes lung cancer medications made by Roche, XTANDI® (enzalutamide) made by Astellas, and Zoladex® (goserelin) made by AstraZeneca. 

If you are prescribed one of these medications, speak to your doctor about enrolling in the CancerAid Plus Program.

If you are not prescribed any of these medications, you can still download and use the free CancerAid app. 

Developed by